Drug Development and Regulation SL

Drug Development and Regulation SL is an SME in Barcelona, Spain that has taken part in 2 EU-funded projects since 2017, receiving €183k in EU funding.

EU funding received€183k
EU projects2
As coordinator0
Running now0
First EU project2017
Latest project2021
CountrySpain
EU registration (PIC)937301107
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Drug Development and Regulation SL's own share of each project, not the project's full budget.

  • Horizon 2020€183k · 1 project
  • Horizon Europe€0 · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • RBDCOVAssociated partner

    RBD Dimer recombinant protein vaccine against SARSCoV2

    Horizon Europe · 2021–2025 · Project on CORDIS ↗

  • Smart-4-FabryPartner

    Smart multifunctional GLA-nanoformulation for Fabry disease

    Horizon 2020 · 2017–2020 · Project on CORDIS ↗

    €183ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • coronaviruses
  • enzymes
  • industrial biotechnology
  • nanomedicine
  • pathology
  • proteins
  • toxicology
  • vaccines

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime